Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06887829

Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial

The primary aim of this study is to investigate whether low-dose radiotherapy is an effective treatment to reduce the pain of knee osteoarthritis. A secondary aim is to determine whether patients experience any more measurable side effects than those receiving sham treatments.

Recruiting

Interested in participating?

Request Info

Key information

Age range

50 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location status: Recruiting

Location contact

Family Medicine Research Study Coordinators

CONTACT

[email protected]

507-422-6823

About this study

This single center, single-blinded, sham-controlled randomized controlled trial will compare low dose radiation therapy and sham radiation therapy for knee osteoarthritis. Participants with symptomatic knee OA based on clinical and radiographic criteria will be randomized 1:1 to receive 0.5 Gy LDRT over 2 weeks ideally on a Monday-Wednesday-Friday three times each week for two weeks treatment course for a total of 3 Gray or identical sham treatment (an identical procedure without the radiation). Non-responders to the initial Low-Dose Radiotherapy (LDRT)/sham treatment will receive a second treatment course of 0.5 Gy Low-Dose Radiotherapy (LDRT) or sham repeat treatment course over 2 weeks x 6 depending on their randomization (treatment arm participants receiving a second treatment course and sham arm participants receiving a second course of identical sham treatments without radiation). Intermittent and Constant Osteoarthritis Pain (ICOAP) outcome scales will be emailed to all participants for completion at baseline and weekly for six months. The study will thus terminate after all participants have completed 6 months of time in the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • patient's primary care provider is at Mayo Clinic in Rochester, MN
  • age 50-100 years
  • ICOAP pain scale A1 at least moderate intensity or B6 at least moderate intensity
  • diagnosed with primary knee OA ICD-10 codes M17.x

o You have not had recurrent episodes of sudden onset of warmth, redness, or swelling of the affected knee

  • physical exam findings of medial or lateral joint line tenderness on palpation that is in the same location as the knee pain.
  • absence of primary knee pain in the pes anserine or hamstring or gastrocnemius, quadriceps, or patellar tendons on exam.
  • radiographic Kellgren-Lawrence grade 2-3 on 4-view knee x-rays taken within the last year ability to complete surveys electronically by email

Exclusion criteria

  • • Kellgren-Lawrence grade 1 or 4
  • pregnancy or women 54 years and younger with potential for pregnancy (if they or their partner have not had tubal ligation, hysterectomy, or vasectomy)
  • history of ipsilateral intraarticular knee surgery
  • use of injected corticosteroids within 3 months or hyaluronans within 6 months or within 1 month if there was no sustained improvement post-injection of either corticosteroid or hyaluronan.
  • history of trauma to this knee in the last year that clearly caused the pain now present
  • history of RA, gout, pseudogout, hemarthroses (eg, hemophilic arthropathy) or other inflammatory arthritis involving this knee
  • history of symptomatic hip OA
  • history of psychosis, personality disorder, uncontrolled affective disorder
  • history of fibromyalgia
  • malignancy requiring active treatment current regular use of opiate analgesics, PRP, or acupuncture for the knees

Treatment and study plan

Low dose radiotherapy

Radiation

Participants will receive low dose radiotherapy (0.5 Gy) 3 times per week, for two weeks delivered via the X-Strahl Orthovoltage device.

Sham Comparator

Other

Participants will receive identical treatment 3 times per week, for two weeks delivered via the X-Strahl Orthovoltage device, without radiation.

Primary outcomes

  1. Change in Area Under the Curve (AUC) of ICOAP Scores

    Time frame: Baseline, 6 months

    Change in the Intermittent and Constant Osteoarthritis Pain (ICOAP) outcome scale weekly for six months after intervention analyzed as area under the curve of patients with Kellgren-Lawrence grade 2-3 knee OA.

  2. Analgesic use frequency in treatment vs. sham participants

    Time frame: 6 months

    Differences in the rate of improvement between the 2 groups with analysis to include time points of 2 months and 4 months after intervention.

Study contacts

Contact information is provided by the study sponsor or research team.

Family Medicine Research Study Coordinators

CONTACT

[email protected]

507-422-6823

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

The Randomized Clinical Trial of Low-Dose Radiotherapy for Knee Osteoarthritis

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 20, 2025
Registry last updated
Jun 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.